BAM
Blueshift Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-973
| Closed | -$617K | – | 574 |
|
|
2025
Q1 | $617K | Sell |
973
-330
| -25% | -$209K | 0.24% | 106 |
|
|
2024
Q4 | $928K | Buy |
1,303
+964
| +284% | +$687K | 0.34% | 65 |
|
|
2024
Q3 | $356K | Buy |
+339
| New | +$356K | 0.09% | 246 |
|
|
2023
Q3 | – | Sell |
-1,400
| Closed | -$1.01M | – | 396 |
|
|
2023
Q2 | $1.01M | Buy |
+1,400
| New | +$1.01M | 0.38% | 57 |
|
|
2023
Q1 | – | Sell |
-330
| Closed | -$238K | – | 440 |
|
|
2022
Q4 | $238K | Buy |
+330
| New | +$238K | 0.11% | 268 |
|
|
2022
Q1 | – | Sell |
-793
| Closed | -$501K | – | 1082 |
|
|
2021
Q4 | $501K | Sell |
793
-789
| -50% | -$498K | 0.04% | 475 |
|
|
2021
Q3 | $957K | Buy |
+1,582
| New | +$957K | 0.05% | 417 |
|
|
2021
Q2 | – | Sell |
-2,282
| Closed | -$1.08M | – | 1128 |
|
|
2021
Q1 | $1.08M | Buy |
+2,282
| New | +$1.08M | 0.11% | 255 |
|
|
2020
Q1 | – | Sell |
-11,019
| Closed | -$4.14M | – | 581 |
|
|
2019
Q4 | $4.14M | Buy |
11,019
+9,389
| +576% | +$3.53M | 0.47% | 27 |
|
|
2019
Q3 | $452K | Buy |
+1,630
| New | +$452K | 0.07% | 398 |
|
|
2019
Q2 | – | Sell |
-890
| Closed | -$365K | – | 928 |
|
|
2019
Q1 | $365K | Buy |
+890
| New | +$365K | 0.05% | 472 |
|